Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Tarnow

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
Diabetes Technology & Therapeutics|March 30, 2013
Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemiaChristiane Bay, Peter Lommer Kristensen, Ulrik Pedersen-Bjergaard, et al.
Trials|October 12, 2017
The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trialFrances Game, William Jeffcoate, Lise Tarnow, et al.
Diabetes Research and Clinical Practice|February 24, 2009
Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patientsAndreas Kjaer, Ulrik Sloth Kristoffersen, Lise Tarnow, et al.
Cardiovascular Diabetology|August 24, 2010
Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility studyLouise Lundby-Christensen, Thomas P Almdal, Bendix Carstensen, et al.
Diabetes|May 5, 2009
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort studyPeter Hovind, Peter Rossing, Lise Tarnow, et al.
Endocrinology, Diabetes & Metabolism|September 10, 2021
Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factorsCarina Kirstine Klarskov, Elena von Rohden, Birger Thorsteinsson, et al.
Diabetes Care|February 28, 2004
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesLise Tarnow, Peter Hovind, Tom Teerlink, et al.
Diabetes Care|December 29, 2007
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyMaria Lajer, Lise Tarnow, Anders Jorsal, et al.
European Journal of Endocrinology|December 31, 2005
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patientsLars Melholt Rasmussen, Lise Tarnow, Troels Krarup Hansen, et al.
Journal of the American Society of Nephrology : JASN|October 22, 2003
Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathyPeter Jacobsen, Lise Tarnow, Bendix Carstensen, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
Diabetes Technology & Therapeutics|March 30, 2013
Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemiaChristiane Bay, Peter Lommer Kristensen, Ulrik Pedersen-Bjergaard, et al.
Trials|October 12, 2017
The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trialFrances Game, William Jeffcoate, Lise Tarnow, et al.
Diabetes Research and Clinical Practice|February 24, 2009
Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patientsAndreas Kjaer, Ulrik Sloth Kristoffersen, Lise Tarnow, et al.
Cardiovascular Diabetology|August 24, 2010
Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility studyLouise Lundby-Christensen, Thomas P Almdal, Bendix Carstensen, et al.
Diabetes|May 5, 2009
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort studyPeter Hovind, Peter Rossing, Lise Tarnow, et al.
Endocrinology, Diabetes & Metabolism|September 10, 2021
Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factorsCarina Kirstine Klarskov, Elena von Rohden, Birger Thorsteinsson, et al.
Diabetes Care|February 28, 2004
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesLise Tarnow, Peter Hovind, Tom Teerlink, et al.
Diabetes Care|December 29, 2007
Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyMaria Lajer, Lise Tarnow, Anders Jorsal, et al.
European Journal of Endocrinology|December 31, 2005
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patientsLars Melholt Rasmussen, Lise Tarnow, Troels Krarup Hansen, et al.
Journal of the American Society of Nephrology : JASN|October 22, 2003
Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathyPeter Jacobsen, Lise Tarnow, Bendix Carstensen, et al.
Pageof 19